Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
MercadoLibre $1.5 billion follow-on offering
The shares are listed on the Nasdaq Global Market
Telefónica Móviles Chile $500 million senior notes offering
We advised Telefónica Móviles Chile on its investment-grade debt offering
Travel + Leisure $650 million senior secured notes offering
The high-yield notes are due 2029
General Mills €500 million notes offering
The investment-grade notes are due 2025
MGP Ingredients $201.25 million convertible senior notes offering
The 1.875% convertible notes are due 2041
Apria $141.7 million secondary offering
The shares are listed on the Nasdaq Global Select Market
First Advantage $345 million secondary offering
The shares are listed on the Nasdaq Global Select Market
Pacific Gas and Electric $1.75 billion first mortgage bonds offering
The investment-grade bonds are due 2022, 2023 and 2031
Revolution Medicines $250 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
SiTime $518 million follow-on offering
The shares are listed on the Nasdaq Global Market